View Article

  • Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes

  • 1Appasaheb Birnale College of Pharmacy, Sangli
    2Dr. Shivajirao Kadam College of Pharmacy

Abstract

Now day?s Recent advances in the understanding of pharmacokinetic & pharmacodynamic behaviour of drug have offer a more rational approach to the development of optimal drug delivery system. Now it's appreciable that future success in Drug delivery research will largely be result of multidisplinary efforts. If any therapeutic agent that can be the more efficacious and safe using and improved drug delivery system represent both lucrative marketing opportunities for pharmaceutical company and advancement in the treatment of diseases of mindkind. An ideally design drug delivery system delivers a specified amount of drug to target particular site at an appropriate time and rate as dictated or desired by the etiological and physiological needs of the body. Conventional Pharmaceutical Dosage forms are incapable of controlling the rate of drug delivery to target site. As a result the distribution of drug in nontarget tissue and body fluids necessitate therapeutic doses that could far exceed the amount required in target cells, the higher doses often lead to serious adverse during treatment thus, the novel drug delivery systems (NDDS) are carriers which maintain the drug concentration in therapeutic range for longer period of time and also, in addition, may deliver the content to the site of action if so desired as per requirements.

Keywords

Drug delivery systems, therapeutic agent, diseases, target site, body fluids, non- targeting tissues, drug etc

Introduction

Novel drug delivery systems is the new system Recent advances in the understanding of pharmacokinetic & pharmacodynamic behaviour of drug have offer a more rational approach to the development of optimal drug delivery system. the novel drug delivery systems (NDDS) are carriers which maintain the drug concentration in therapeutic range for longer period of time There are several advantages of novel drug delivery systems over conventional drug delivery.

1. Optimum therapeutic- drug concentration in the blood or in tissue may be maintained over a prolonged period of time.

2. Pre- determined release rates of extended period of time may be achieved.

3. Duration for short half- life drug may be increased.

4. By targeting the site of action, side effects may be eliminated.

5. Frequent dosing and wastage of the drug may be reduced or excluded. 6. Better patient compliance may be ensured.

Novel drug delivery systems

• Sustained- or controlled- drug delivery systems provide drug action at a pre-determined rate by providing a prolonged or constant (Zero-order) release respectively, at the therapeutically effective levels in the circulation.

• Localized drug delivery devices provide drug action through spatial or temporal control of drug release (usually rate- limiting) in the vicinity of the target.

• Rate- pre-programmed drug delivery systems provide drug action by manipulating the release of drug molecules by system design which control the molecular diffusion of drug molecules.

• Targeted drug delivery provides drug action by using carries either for passive or active targeting or one base or self-programmed approach, usually anchored with suitable sensory devices, which recognize their receptor at the target.

Table 1.0 Classification of sustained or controlled release system based on their rate – controlled mechanism.

Type of System                                     

Rate control Mechanism

Diffusion – controlled

 

Reservoir systems (Ocusert)

Diffusion through membrane

Monolithic systems (Transdermal drug)

Diffusion through membrane

Delivery system- Nitro -dur)

 

Water penetration controlled

 

Osmotic systems (Oros, Alzet osmotic pump)

Osmotic transport of water through semi-permeable membrane

Swelling system (hydrogel)

Water penetration into glassy polymer

Chemically - controlled

 

Pendent systems

Combination of hydrolysis of pendent group diffusion from bulk polymer

Ion – exchange resins

Exchange of acidic or basic drug with the ions present on resins

Reference

  1. Roop k khar, s.p vyas, farhan j ahmed, gaurav k jain “the theory and practice of industrial pharmacy “4th edition lachman’s/lieberman’s cbs distributors, 2013; 872, 902, 905, 943.
  2. Charman w.n, chan k, finnin BC & chairman SA drug delivery: a key factor in realising the full therapeutic potential of drug. Drug development research, 1999; 46: 316-27.
  3. Santini JT, Richards Ac, scheidt R, cima MJ and longer R. Microchips as controlled drug delivery devices angew chem. Int. Td, 2000; 39: 23, 96-407.
  4. Kopeek J. Smart & genetically engineered biomaterials & drug delivery systems. European journal pharmaceutical science, 2003; 20: 1-16.
  5. Torchilin v.p structure & design polymeric surfactant- based drug delivery systems, journal of controlled release, 2001; 73: 137-172.
  6. Haag R. Supramolecular Drug-Delivery Systems based on Polymeric Core-Shell Architectures. Angew. Chem. Int. Ed, 2004; 43: 278-82.
  7. Bae Y, Fukushima S, Harada A and Kataoka K, Design of Environment-Sensitive Supramolecular Assemblies for Intracellular Drug Delivery. Polymeric Micelles that are Responsive to Intracellular pH Change. Angew. Chem. Int. Ed, 2003; 4640: 42-43.
  8. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 2001; 70: 1-20.
  9. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro and nanoparticles in drug delivery. Journal of Controlled Release, 2004; 100: 5-28.
  10. lByrne ME, Park K, Peppas N. Molecular imprinting within hydrogels, Advanced Drug Delivery Reviews 2002; 54: 149-61.
  11. Sood A and Panchagnula R. Peroral Route: An Opportunity for Protein and Peptide Drug Delivery.Chemical Reviews, 2000; 101: 3275-303.
  12. Niculescu-Duvaz I, Springer CJ. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Advanced Drug Delivery Reviews, 1997; 26: 151-72.
  13. Alvarez-Lorenzo C, Concheiro A, Molecular imprinted polymers for drug delivery. Journal of Chromatography, 2004; 804: 231-45.
  14. Winterhalter M, Hilty C, Bezrukov S M, Nardin C, Meier W, Fournier D. Controlling membrane permeability with bacterial porins. Applications to encapsulated enzymes. Talanta 2001; 55: 965-71.
  15. Jiang W, Kim BY, Rutka JT, Chan WC. Expert Opin. Drug Delivery 2007; 4: 621- 633.
  16. Bonard JM, Kind H, Stockli, Nilsson LA. Field Emission from Carbon Nanotubes: The First Five Years. Solid-State Electronics 2001; 45: 893 – 914.
  17. Ajayan PM. Nanotubes from Carbon, Chem. Rev. 1999; 1787–99.
  18. Dresselhaus MS, Dresselhaus G, Eklund PC. Science of Fullerenes and Carbon Nanotubes. Academic Press; New York, 1996.
  19. Santini JT, Richards AC, Scheidt R, Cima MJ, Langer R. Nature, 1999; 397: 335.
  20. P. Dario, MC Carrozza, A Benvenuto, A Menciassi, J Micromech. Microeng, 2000; 10.
  21. Bruguolle B, Lemmer B. Recent advances in Chrono pharmacokinetics “methodological problems. Life Sci, 1993; 52: 1809-1824.
  22. Lalla J K, Mamania, H M. Indian J. Pharm. Sci, 2004; 59(4): 23-26.
  23. Corveleyn S, Remon, JP. Int. J. Pharm, 1997; 152: 215-225.
  24. Tomalia DA, Reyna LA, Svenson S: Biochem. Soc. Trans, 2007; 35: 61-67.
  25. Szoka F. Annu. Rev. Biophys. Bioeng, 1980; 9: 467-508.
  26. Toth E, Bolskar RD, Borel A et al. J. Am. Chem. Soc, 2005; 127: 799-805.
  27. Bolskar RD, Benedetto AF, Husebo LO et al. J Am. Chem. Soc, 2003; 125: 5471-5478.
  28. Sitharaman B, Tran LA, Pham QP et al. Contrast Media Mol. Imaging, 2007; 2: 139-146.
  29. Kamal Singh Rathore, Rohit lowalekar, Nema RK, The Pharma Review, 2006; 30-32.
  30. Chan WCW: In: Bio-Applications of Nanoparticles. 2007, Landes Bioscience, Austin, TX, USA.

Photo
Satyam Ambardekar
Corresponding author

Appasaheb Birnale College of Pharmacy, Sangli

Satyam Ambardekar*, Anuradha Chavan, Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes, Int. J. Sci. R. Tech., 2025, 2 (6), 608-614. https://doi.org/10.5281/zenodo.15718612

More related articles
Formulation and Evaluation of Etoposide Liposomal ...
Rushikesh Nirgude, Vedika Pagar, Ragini Kadvekar, ...
Design, Development and Synthesis of Herbal Lipsti...
C. Sakthivel Chinnathambi, G. Ashok, ...
AI Content Generator SaaS Product Using Next. JS a...
Purushottam Kumar, Shashank Sekhar, Rani Singh, ...
A Study on Design of G+1 Residential Building...
Sudhanshu Kumar Soni, Rahul Gupta, Jyotsna Kosley, Harshudha Bharti, Dr. Ajay Kumar Garg, ...
Related Articles
Review on Probiotics as A Health Supplement...
Prapti Chakraborty, Subhajit Patra, Priyanka Ray, ...
Amplifying Awareness: The Media's Role in Environmental Advocacy in Iraq...
Ali Mohammed Salih, Mohammed Satar Saeed, Rawezh Kamaran Ahmed, Hataw Hussein, Yohan Othman Hama, Ka...
Formulation and Evaluation of Etoposide Liposomal Drug Delivery Systems...
Rushikesh Nirgude, Vedika Pagar, Ragini Kadvekar, ...
More related articles
Formulation and Evaluation of Etoposide Liposomal Drug Delivery Systems...
Rushikesh Nirgude, Vedika Pagar, Ragini Kadvekar, ...
AI Content Generator SaaS Product Using Next. JS and LLM...
Purushottam Kumar, Shashank Sekhar, Rani Singh, ...